Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    March 2019
  1. SHARMA A, Coles A, Sekaran NK, Pagidipati NJ, et al
    Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease.
    J Am Coll Cardiol. 2019;73:893-902.
    PubMed     Text format     Abstract available


    February 2019
  2. MCHUGH K, DeVore AD, Wu J, Matsouaka RA, et al
    Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:602-611.
    PubMed     Text format     Abstract available


  3. FARKOUH ME, Sidhu MS, Brooks MM, Vlachos H, et al
    Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
    J Am Coll Cardiol. 2019;73:400-411.
    PubMed     Text format     Abstract available


    December 2018
  4. LOW WANG CC, Blomster JI, Heizer G, Berger JS, et al
    Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial.
    J Am Coll Cardiol. 2018;72:3274-3284.
    PubMed     Text format     Abstract available


  5. LU J, Wang W, Li M, Bi Y, et al
    Associations of Hemoglobin A1c With Cardiovascular Disease and Mortality in Chinese Adults With Diabetes.
    J Am Coll Cardiol. 2018;72:3224-3225.
    PubMed     Text format    


  6. KATO K, Cammann VL, Wischnewsky M, Ghadri JR, et al
    Reply: Prevalence of Diabetes Mellitus in Patients With Takotsubo Syndrome, Precipitated by Nonphysical or No Triggers.
    J Am Coll Cardiol. 2018;72.
    PubMed     Text format    


  7. MADIAS JE
    Prevalence of Diabetes Mellitus in Patients With Takotsubo Syndrome, Precipitated by Nonphysical or No Triggers.
    J Am Coll Cardiol. 2018;72.
    PubMed     Text format    


  8. FEDAK PWM, Bhatt DL, Verma S
    Coronary Bypass Surgery for Diabetes and Multivessel Disease: Forget the SYNTAX.
    J Am Coll Cardiol. 2018;72.
    PubMed     Text format    


  9. ESPER RB, Farkouh ME, Ribeiro EE, Hueb W, et al
    SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial.
    J Am Coll Cardiol. 2018;72.
    PubMed     Text format     Abstract available


    November 2018
  10. DAS SR, Everett BM, Birtcher KK, Brown JM, et al
    2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus
    J Am Coll Cardiol. 2018 Nov 24. pii: S0735-1097(18)38498.
    PubMed     Text format    


  11. BANGALORE S, Zenati MA
    The "Fragility" of Mortality benefit of Coronary Artery Bypass Graft Surgery in Diabetics.
    J Am Coll Cardiol. 2018 Nov 5. pii: S0735-1097(18)39064.
    PubMed     Text format    


  12. FARKOUH ME, Domanski M, Dangas GD, Godoy LC, et al
    Long-term Survival following Multivessel Revascularization in Patients with Diabetes (FREEDOM Follow-On Study).
    J Am Coll Cardiol. 2018 Nov 1. pii: S0735-1097(18)38994.
    PubMed     Text format     Abstract available


    October 2018
  13. NEWMAN JD, Vani AK, Aleman JO, Weintraub HS, et al
    The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018;72:1856-1869.
    PubMed     Text format     Abstract available


  14. DEEDWANIA P
    Dangers of Hypoglycemia in Cardiac Patients With Diabetes: Time to Switch to Safer, Newer Drugs.
    J Am Coll Cardiol. 2018;72:1787-1789.
    PubMed     Text format    


  15. REZENDE PC, Everett BM, Brooks MM, Vlachos H, et al
    Hypoglycemia and Elevated Troponin in Patients With Diabetes and Coronary Artery Disease.
    J Am Coll Cardiol. 2018;72:1778-1786.
    PubMed     Text format     Abstract available


    September 2018
  16. EVERETT BM, Ridker PM
    Reply: Inflammatory Pathways in CVD and Diabetes: Broad-Spectrum Versus Selective Targeting.
    J Am Coll Cardiol. 2018;72:1432-1433.
    PubMed     Text format    


  17. PAREEK AK, Messerli FH, Mehta RT, Grover A, et al
    Inflammatory Pathways in CVD and Diabetes: Broad-Spectrum Versus Selective Targeting.
    J Am Coll Cardiol. 2018;72:1432.
    PubMed     Text format    


  18. KARAYIANNIDES S, Norhammar A, Frobert O, James SK, et al
    Prognosis in Patients With Diabetes Mellitus and STEMI Undergoing Primary PCI.
    J Am Coll Cardiol. 2018;72:1427-1428.
    PubMed     Text format    


  19. BAKRIS GL, Polonsky TS
    Presence of Diabetes Does Not Mandate Lower Blood Pressure to Reduce Cardiovascular Events.
    J Am Coll Cardiol. 2018;72:1224-1226.
    PubMed     Text format    


  20. BERKOWITZ SA, Sussman JB, Jonas DE, Basu S, et al
    Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus.
    J Am Coll Cardiol. 2018;72:1214-1223.
    PubMed     Text format     Abstract available


    August 2018
  21. VILAHUR G
    Red Blood Cells Deserve Attention in Patients With Type 2 Diabetes.
    J Am Coll Cardiol. 2018;72:781-783.
    PubMed     Text format    


  22. ZHOU Z, Mahdi A, Tratsiakovich Y, Zahoran S, et al
    Erythrocytes From Patients With Type 2 Diabetes Induce Endothelial Dysfunction Via Arginase I.
    J Am Coll Cardiol. 2018;72:769-780.
    PubMed     Text format     Abstract available


    July 2018
  23. ZELNIKER TA, Braunwald E
    Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018 Jul 24. pii: S0735-1097(18)35368.
    PubMed     Text format     Abstract available


    June 2018
  24. CONNELLY K, Gandhi S, Horton E
    Lifestyle and CV Risk in Patients With Diabetes: Time to Get "Back to Basics".
    J Am Coll Cardiol. 2018;71:2877-2879.
    PubMed     Text format    


  25. LIU G, Li Y, Hu Y, Zong G, et al
    Influence of Lifestyle on Incident Cardiovascular Disease and Mortality in Patients With Diabetes Mellitus.
    J Am Coll Cardiol. 2018;71:2867-2876.
    PubMed     Text format     Abstract available


    May 2018
  26. VERMA S, Mathew V, Farkouh ME
    Targeting Inflammation in the Prevention and Treatment of Type 2 Diabetes: Insights From CANTOS.
    J Am Coll Cardiol. 2018;71:2402-2404.
    PubMed     Text format    


    March 2018
  27. GREENE SJ, Vaduganathan M, Khan MS, Bakris GL, et al
    Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes.
    J Am Coll Cardiol. 2018 Mar 10. pii: S0735-1097(18)30326.
    PubMed     Text format     Abstract available


  28. EVERETT BM, Donath MY, Pradhan AD, Thuren T, et al
    Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes.
    J Am Coll Cardiol. 2018 Mar 3. pii: S0735-1097(18)33483.
    PubMed     Text format     Abstract available


    February 2018
  29. VELAZQUEZ EJ, Petrie MC
    CABG or PCI for Diabetic Patients With Left Ventricular Dysfunction: Closing in on the Truth?
    J Am Coll Cardiol. 2018;71:828-831.
    PubMed     Text format    


  30. NAGENDRAN J, Bozso SJ, Norris CM, McAlister FA, et al
    Coronary Artery Bypass Surgery Improves Outcomes in Patients With Diabetes and Left Ventricular Dysfunction.
    J Am Coll Cardiol. 2018;71:819-827.
    PubMed     Text format     Abstract available


  31. PAREEK M, Schauer PR, Kaplan LM, Leiter LA, et al
    Metabolic Surgery: Weight Loss, Diabetes, and Beyond.
    J Am Coll Cardiol. 2018;71:670-687.
    PubMed     Text format     Abstract available


    January 2018
  32. FITCHETT D, Inzucchi SE, Lachin JM, Wanner C, et al
    Cardiovascular Mortality Reduction With Empagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease.
    J Am Coll Cardiol. 2018;71:364-367.
    PubMed     Text format    


  33. MARWICK TH, Ritchie R, Shaw JE, Kaye D, et al
    Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
    J Am Coll Cardiol. 2018;71:339-351.
    PubMed     Text format     Abstract available


    December 2017
  34. BANGALORE S, Bhatt DL
    Do We Need a Trial of DES Versus CABG Surgery in Diabetic Patients With ACS?
    J Am Coll Cardiol. 2017;70:3007-3009.
    PubMed     Text format    


  35. RAMANATHAN K, Abel JG, Park JE, Fung A, et al
    Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes.
    J Am Coll Cardiol. 2017;70:2995-3006.
    PubMed     Text format     Abstract available


    November 2017
  36. AGIRBASLI M
    Influence of Diabetes on CABG Patency: Targeting Functional Status After CABG in Patients With DM.
    J Am Coll Cardiol. 2017;70:2604.
    PubMed     Text format    


    October 2017
  37. HONG KN, Fuster V, Rosenson RS, Rosendorff C, et al
    How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD.
    J Am Coll Cardiol. 2017;70:2171-2185.
    PubMed     Text format     Abstract available


  38. DOMINGUEZ H, Sanchez-Ferrer CF
    The Role of Glycated Proteins on Cardiovascular Diabetic Complications: New Findings.
    J Am Coll Cardiol. 2017;70:2020-2021.
    PubMed     Text format    


  39. DAI Y, Shen Y, Li QR, Ding FH, et al
    Glycated Apolipoprotein A-IV Induces Atherogenesis in Patients With CAD in Type 2 Diabetes.
    J Am Coll Cardiol. 2017;70:2006-2019.
    PubMed     Text format     Abstract available


  40. GALDERISI M, Esposito R, Trimarco B
    Cardiac Involvement in Diabetes: The Dark Side of the Moon.
    J Am Coll Cardiol. 2017;70:1717-1719.
    PubMed     Text format    


  41. ERNANDE L, Audureau E, Jellis CL, Bergerot C, et al
    Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus.
    J Am Coll Cardiol. 2017;70:1704-1716.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: